Cardarine GW501516 was developed in the 1990s as a potential treatment for cardiovascular disease, obesity, and diabetes. However, it was discontinued in 2007 after it was linked to the rapid development of cancer during trials on mice. It has since become popular among the weight-lifting community for boosting metabolism, enhancing fat loss, and increasing muscle growth.
Read more